We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$80.5B
AUM Growth
-$3.46B
(-4.1%)
Cap. Flow
-$1.21B
Cap. Flow
% of AUM
-1.5%
Top 10 Holdings %
Top 10 Hldgs %
13.64%
Holding
817
New
51
Increased
266
Reduced
358
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$499M |
| 2 |
Fidelity National Information Services
FIS
|
+$462M |
| 3 |
Honeywell
HON
|
+$367M |
| 4 |
Lennar Class A
LEN
|
+$321M |
| 5 |
Extra Space Storage
EXR
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$486M |
| 2 |
Global Payments
GPN
|
+$421M |
| 3 |
Eaton
ETN
|
+$415M |
| 4 |
Dell
DELL
|
+$391M |
| 5 |
Howmet Aerospace
HWM
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.82% |
| 2 | Technology | 16.67% |
| 3 | Industrials | 16.22% |
| 4 | Healthcare | 11.1% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JFIN
676
Jiayin Group
JFIN
$110M
| $421K | ﹤0.01% |
67,362
| – | – |
|
677
RingCentral
RNG
$5.77B
| $408K | ﹤0.01% |
+32,719
| New | +$1.05M |
|
|
PNST
678
DELISTED
Pinstripes Holdings, Inc.
PNST
| $406K | ﹤0.01% |
147,484
| – | – |
|
|
DENN
679
DELISTED
Denny's
DENN
| $399K | ﹤0.01% |
56,175
+34,620
| +161% | +$267K |
|
680
RCM Technologies
RCMT
$294M
| $394K | ﹤0.01% |
21,066
| – | – |
|
681
CareDx
CDNA
$2.61B
| $377K | ﹤0.01% |
+24,289
| New | +$294K |
|
682
Caterpillar
CAT
$368B
| $375K | ﹤0.01% |
1,125
-296
| -21% | -$103K |
|
683
Driven Brands
DRVN
$2.08B
| $370K | ﹤0.01% |
114,185
+6,118
| +6% | +$77.4K |
|
684
nLIGHT
LASR
$2.49B
| $365K | ﹤0.01% |
33,412
+22,567
| +208% | +$274K |
|
685
Star Holdings Shares of Beneficial Interest
STHO
$119M
| $349K | ﹤0.01% |
28,955
| – | – |
|
|
NXH
686
Neighborhood Intelligence Inc
NXH
$376M
| $337K | ﹤0.01% |
28,361
-37,902
| -57% | -$673K |
|
687
AstraZeneca
AZN
$251B
| $309K | ﹤0.01% |
1,973
-272
| -12% | -$40.9K |
|
|
AUGX
688
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $272K | ﹤0.01% |
309,310
+170,902
| +123% | +$352K |
|
689
Thermo Fisher Scientific
TMO
$229B
| $261K | ﹤0.01% |
472
-334
| -41% | -$191K |
|
690
MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038
FNGD
$312M
| $253K | ﹤0.01% |
+1,027
| New | +$340K |
|
|
FFWM
691
DELISTED
First Foundation Inc
FFWM
| $237K | ﹤0.01% |
36,110
+19,187
| +113% | +$118K |
|
692
TechTarget
TTGT
$281M
| $228K | ﹤0.01% |
+7,324
| New | +$217K |
|
693
Goodyear
GT
$1.75B
| $208K | ﹤0.01% |
53,848
-21,262
| -28% | -$260K |
|
694
Argan
AGX
$6.02B
| $203K | ﹤0.01% |
+2,768
| New | +$181K |
|
|
HERE
695
Here Group Ltd
HERE
$100M
| $162K | ﹤0.01% |
98,007
| – | – |
|
696
Aqua Metals
AQMS
$9.95M
| $128K | ﹤0.01% |
2,003
-1,077
| -35% | -$98.6K |
|
697
Fathom Holdings
FTHM
$23.4M
| $92.2K | ﹤0.01% |
+53,612
| New | +$89.2K |
|
698
Compass
COMP
$8.51B
| $82.2K | ﹤0.01% |
22,838
-41,116
| -64% | -$151K |
|
699
Lifecore Biomedical
LFCR
$175M
| $72.9K | ﹤0.01% |
14,212
-5,462
| -28% | -$32.3K |
|
700
Lloyds Banking Group
LYG
$85.6B
| $30.9K | ﹤0.01% |
+10,248
| New | +$27.5K |
|
Similar funds
Boston Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Boston Partners held 817 positions worth $80.5B, down 4.1% from $84B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Boston Partners's Q2 2024 filing shows 51 new, 266 increased, 358 reduced and 117 closed positions. Its largest new stake was Honeywell: 1,930,615 shares worth $389M. The largest sale was Sanofi, an estimated $486M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q2 2024 buy was Honeywell: 1,930,615 shares worth $389M.
- Boston Partners added most to AbbVie in Q2 2024, an estimated $499M increase.
- Boston Partners's biggest Q2 2024 reduction was Sanofi, cutting an estimated $486M.
- Boston Partners fully exited Globe Life in Q2 2024, selling an estimated $243M.
- Boston Partners's ten largest holdings make up 14% of its $80.5B portfolio in Q2 2024.
- Boston Partners opened 51 new positions and closed 117 in Q2 2024.
- Boston Partners's portfolio value fell 4.1% quarter-over-quarter to $80.5B.
Based on Boston Partners's 13F filing for Q2 2024, filed 14 Aug 2024.